Whitehawk Therapeutics, Inc. (Nasdaq: WHWK) said President and CEO Dave Lennon, PhD, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Feb. 25, 2026, at 8:40 a.m. EST. A live webcast will be available via the company’s IR website: https://edge.prnewswire.com/c/link/?t=0&l=en&o=4622067-1&h=3120612636&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4100255-1%26h%3D2471710764%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3955997-1%2526h%253D1403846191%2526u%253Dhttps%25253A%25252F%25252Fir.aadibio.com%25252Fevent-calendar%2526a%253Dwebsite%26a%3Dwebsite&a=website. The original announcement is available at https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-302691346.html.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602180800PR_NEWS_USPR_____LA90292) on February 18, 2026, and is solely responsible for the information contained therein.